Advertisement - Hide this advert

Author Topic: Invossa ( cartilage regeneration drug ) soon to be available in many countries  (Read 112 times)

0 Members and 1 Guest are viewing this topic.

Offline neptronix

  • MINIgeek (20-50 posts)
  • **
  • Posts: 32
  • Liked: 4
Invossa has been in development for around 20 years and is shown to increase cartilage thickness. It is currently in phase 3 trials in the United States.

It is currently used in Korea and China, but distribution and sales will be expanding to Australia, New Zealand, and many countries in Asia.

It's prime competitor, Sprifermin, hasn't had much news in the last year. Will update when i hear more.

Offline Brandon123

  • Forum Faithful
  • ****
  • Posts: 373
  • Liked: 34
Interesting, thanks for the update!
RK sharp pain while running, diagnosis chondromalacia patellae 6/09
RK arthroscopic chondroplasty 9/09
RK rehab, recovery, 90% normal, started running again -> back to square one 5/15
RK diagnosis patellofemoral arthritis + LK diagnosis chondromalacia patellae 8/15 -> conservative treatment

Offline db1984

  • MINIgeek (20-50 posts)
  • **
  • Posts: 23
  • Liked: 2
  • Knee OA, going all out with cultured MSCs!

See the above link for a paper they published on MRI findings after Invossa treatment. Although they're seeing cartilage repair and delay of cartilage degeneration, one of the things I find discouraging is that they're not seeing much improvement in bone marrow lesions. This is really important since bone marrow lesions are associated with accelerated OA progression, as well as with knee pain in OA.
Jun 16: Patellofemoral OA, Lumbar DDD
Aug 16: Regenexx-SD left knee, PRP right knee
Mar 17: Bone marrow aspiration for cell culture
Apr 17: Regenexx-C both knees, lumbar spine, left shoulder
Jun 17: PRP both Achilles, right hip, both knees
Jan 18: Knees and back MUCH better, planning 2nd treatment